{"nct_id":"NCT00251433","title":"GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer","status":"TERMINATED","status_verified_date":"2023-03","start_date":"2005-09-26","start_date_type":"ACTUAL","primary_completion_date":"2010-06-10","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-22","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}